---
schema_version: "secwatch.filing_event.v1"
accession: "0000037785-26-000083"
form_type: "8-K"
ticker: "FMC"
cik: "0000037785"
company_name: "FMC CORP"
filed_at: "2026-04-29T23:59:59+00:00"
generated_at: "2026-05-15T02:30:43.611973+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# FMC Q1 net loss $281M, Adj EBITDA $72M above guidance; reaffirms FY outlook

## Summary
- Revenue $759M (-4% YoY); GAAP EPS $(2.25); adj EPS $(0.23); adj EBITDA $72M (-40%).
- Board-authorized strategic alternatives evaluation (since Feb 2026) progressing; no transaction assured.
- FY 2026 guidance reaffirmed: rev $3.6-3.8B, adj EBITDA $670-730M, adj EPS $1.63-1.89, FCF -$65M to $65M.
- Q2 2026 view: rev $850-900M, adj EBITDA $130-150M, adj EPS $0.16-0.26.
- New active ingredient sales doubled YoY; Plant Health grew 6%.

## SEC filing metadata
- accession: 0000037785-26-000083
- form_type: 8-K
- ticker: FMC
- cik: 0000037785
- company_name: FMC CORP
- filed_at: 2026-04-29T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/37785/000003778526000083/0000037785-26-000083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/37785/000003778526000083/fmc-20260429.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000037785-26-000083
- JSON: https://secwatch.observer/filing/0000037785-26-000083.json
- Plain text: https://secwatch.observer/filing/0000037785-26-000083.txt

## Key facts
- Earnings Releases
  FMC CORP reported full-year 2026 results: revenue $3.60 billion to $3.80 billion, EPS $1.63 to $1.89. Guidance reaffirmed.
  - Period: full-year 2026
  - Revenue: $3.60 billion to $3.80 billion
  - EPS: $1.63 to $1.89
  - Guidance: reaffirmed
  - Result: guidance update
  source text: diluted share, down $2.13 versus Q1 2025 • Adjusted loss per diluted share of $0.23, down 41 cents versus Q1 2025 Maintains 2026 Full-Year Outlook 1 • Revenue excluding India of $3.60 billion to $3.80 billion, a decline of 5 percent at the midpoint versus 2025 ◦ Excluding 2025 India contributions the 2026 outlook represents a decline at the midpoint of 3 percent •
  evidence_url: https://www.sec.gov/Archives/edgar/data/37785/000003778526000083/0000037785-26-000083-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.